Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion

Platelet (PLT) and plasma transfusion remain the mainstay hemostatic therapy for perioperative bleeding. Several studies have indicated that acquired fibrinogen (FIB) deficiency can be the primary cause of bleeding after cardiac surgery. The aim of this study was to compare hematologic and transfusion profiles between the first‐line FIB replacement and PLT transfusion in post–cardiac surgical bleeding.

[1]  A. Hanke,et al.  Effects of Fibrinogen Concentrate as First-line Therapy during Major Aortic Replacement Surgery: A Randomized, Placebo-controlled Trial , 2013, Anesthesiology.

[2]  L. Cohn,et al.  Point-of-Care Testing: A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients , 2012, Anesthesiology.

[3]  L. Levin,et al.  Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery. , 2012, British journal of anaesthesia.

[4]  Kenichi A. Tanaka,et al.  Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding , 2012, Anesthesia and analgesia.

[5]  Kenichi A. Tanaka,et al.  A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution‐induced coagulation changes after cardiac surgery , 2012, Transfusion.

[6]  A. Hanke,et al.  First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. , 2011, Anesthesiology.

[7]  H. Schöchl,et al.  A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients , 2011, Transfusion.

[8]  Howard K. Song,et al.  2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. , 2011, The Annals of thoracic surgery.

[9]  W. Chandler,et al.  Development of a rapid emergency hemorrhage panel , 2010, Transfusion.

[10]  B. Sørensen,et al.  A critical evaluation of cryoprecipitate for replacement of fibrinogen , 2010, British journal of haematology.

[11]  W. Voelckel,et al.  Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrate , 2010, Critical care.

[12]  P. Mannucci,et al.  Pharmacokinetics and safety of fibrinogen concentrate , 2009, Journal of thrombosis and haemostasis : JTH.

[13]  N. Nussmeier,et al.  Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer , 2009, Thrombosis and Haemostasis.

[14]  S. Skrtic,et al.  Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery , 2009, Thrombosis and Haemostasis.

[15]  A. Haverich,et al.  Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study , 2009, British journal of anaesthesia.

[16]  J. Ingerslev,et al.  Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo‐controlled clinical trial , 2009, Journal of thrombosis and haemostasis : JTH.

[17]  J. Michalek,et al.  Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients , 2008, Annals of surgery.

[18]  K. Inaba,et al.  Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. , 2008, British journal of anaesthesia.

[19]  R. Martineau,et al.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. , 2008, The New England journal of medicine.

[20]  D. Fergusson,et al.  The future of clinical trials evaluating blood substitutes. , 2008, JAMA.

[21]  S. R. Bueno,et al.  Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high‐risk severe bleeding , 2008, Vox sanguinis.

[22]  C. Wade,et al.  A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. , 2008, The Journal of trauma.

[23]  Jeffrey L. Apfelbaum,et al.  Practice Guidelines for Perioperative Blood Transfusion and Adjuvant Therapies: An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies , 2006, Anesthesiology.

[24]  Andrew D. Rosenberg,et al.  Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on perioperative blood transfusion and adjuvant therapies , 2006 .

[25]  A. Brand,et al.  Independent association of massive blood loss with mortality in cardiac surgery , 2005, Transfusion.

[26]  S. Body,et al.  Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes , 2004, Transfusion.

[27]  Guidelines for the use of platelet transfusions , 2003, British journal of haematology.

[28]  R. Wunderink,et al.  Effect of clopidogrel on bleeding after coronary artery bypass surgery , 2001, Critical care medicine.

[29]  M. Prins,et al.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.

[30]  C. Hogue,et al.  Pathophysiology, prevention, and treatment of bleeding after cardiac surgery: a primer for cardiologists and an update for the cardiothoracic team , 1999 .

[31]  A. Laupacis,et al.  Platelet-rich plasmapheresis in cardiac surgery: a meta-analysis of the effect on transfusion requirements. , 1998, The Journal of thoracic and cardiovascular surgery.

[32]  S. Hiippala.  Replacement of Massive Blood Loss , 1998, Vox sanguinis.

[33]  K. Kanter,et al.  Predicting and Treating Coagulopathies After Cardiopulmonary Bypass in Children , 1997, Anesthesia and analgesia.

[34]  T. Simon,et al.  Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. , 1984, The Annals of thoracic surgery.

[35]  H. Hemker,et al.  Thrombin generation, a function test of the haemostaticthrombotic system , 2006, Thrombosis and Haemostasis.